Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Tiny Microscopes Reveal Hidden Role of Nervous System Cells

By Drug Discovery Trends Editor | April 28, 2016

Salk Institute scientists show the surprising involvement of cells called astrocytes in spinal sensory processing. Here, astrocytes (genetically labeled in green) in a spinal cord (co-stained with glial fibrillary acidic protein, red, to visualize its outline) react to the activity of sensation with their own chemical signals. Credit: Salk InstituteA microscope about the size of a penny is giving scientists a new window into the everyday activity of cells within the spinal cord. The innovative technology revealed that astrocytes—cells in the nervous system that do not conduct electrical signals and were traditionally viewed as merely supportive—unexpectedly react to intense sensation.

The new miniaturized microscope and related imaging methods, described by Salk Institute scientists on April 28, 2016 in Nature Communications, offer unprecedented insight into nervous system function and could lead to novel pain treatments for spinal cord injuries, chronic itch and neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS).

The spinal cord is crucial for sensing and responding to the world. Sometimes it even works independently from the brain, such as when your hand recoils from a hot stove before the sensation has fully registered. But it is unknown exactly how the cells within the spinal cord encode these and other feelings from the skin or internal organs.

In the new study, senior author Axel Nimmerjahn, an assistant professor in Salk’s Waitt Advanced Biophotonics Center, and his team improved upon the miniaturized microscopes they first described back in 2008. The researchers’ new version—which features numerous hardware and software improvements—enabled them to visualize changes in cellular activity in awake, roaming mice.

“For a long time, researchers have dreamed of being able to record cellular activity patterns in the spinal cord of an awake animal. On top of that, we can now do this in a freely behaving animal, which is very exciting,” says first author Kohei Sekiguchi, a Salk researcher and PhD student at the University of California, San Diego.

Most of the Salk team’s previous work focused on deploying microscopes to observe the brains of living animals. The spinal cord, by contrast, presented a bigger challenge for several reasons. For example, unlike the brain, multiple, independently moving vertebrae surround the spinal cord. The spinal cord is also closer to pulsating organs (heart and lungs), which can hinder stable views of the cells within. However, by developing new microscopy and procedural and computational approaches, the team was able to overcome these challenges and capture the action of living cells in real time and during vigorous movements.

In the new work, the group found that distinct stimuli—such as light touch or pressure—activate different subsets of spinal sensory neurons. They also found that certain features, like the intensity or duration of a given stimulus, are reflected in the activity of the neurons.

To the team’s surprise, astrocytes, traditionally thought to be passive support cells, also respond to stimuli (albeit differently than the neurons). Though the astrocytes cannot send electrical signals like neurons can, they generated their own chemical signals in a coordinated way during intense stimuli.

Nimmerjahn is excited about this result because his group has a longstanding interest in understanding astrocytes and their roles in nervous system function and disease. These cells are increasingly appreciated as important players in how the nervous system develops and operates and could serve as promising new drug targets, he says.

“Not only can we now study normal sensory processing, but we can also look at disease contexts like spinal cord injury and how treatments actually affect the cells,” says Nimmerjahn.

The team is now working to simultaneously record touch or pain-related activity in the brain and spinal cord using additional iterations of the miniaturized microscopes, which allow them to monitor and manipulate multiple cell types at even higher resolutions.


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50